Pfizer to seek FDA authorization for 4th booster dose for people 65 and up

Pfizer and BioNTech could seek emergency use authorization from the US Food and Drug Administration for a second booster shot of their Covid-19 vaccine for people 65 and older as soon as Tuesday, in news first reported by The Washington Post.